Literature DB >> 1164847

Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration.

F Z Stanczyk, M Hiroi, U Goebelsmann, P F Brenner, M E Lumkin, D R Mishell.   

Abstract

Entities:  

Keywords:  Bleeding; Clinical Research; Contraception; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--analysis; Diseases; Estradiol; Family Planning; Injectables; Levonorgestrel--analysis; Metrorrhagia; Oral Contraceptives; Progesterone; Research Methodology; Signs And Symptoms; Silastic Ring

Mesh:

Substances:

Year:  1975        PMID: 1164847     DOI: 10.1016/0010-7824(75)90088-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  15 in total

1.  Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.

Authors:  Regine Sitruk-Ware; Vivian Brache; Robin Maguire; Horacio Croxatto; Narender Kumar; Sushma Kumar; Juan Carlos Montero; Ana Maria Salvatierra; David Phillips; Anibal Faundes
Journal:  Contraception       Date:  2007-04-18       Impact factor: 3.375

2.  Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth R Mayeda; Malcolm C Pike; Frank Z Stanczyk
Journal:  Contraception       Date:  2010-02-20       Impact factor: 3.375

3.  Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding.

Authors:  Anne R Davis; Carolyn L Westhoff; Frank Z Stanczyk
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

4.  CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.

Authors:  Gaia Sciaranghella; Cuiwei Wang; Haihong Hu; Kathryn Anastos; Zaher Merhi; Marek Nowicki; Frank Z Stanczyk; Ruth M Greenblatt; Mardge Cohen; Elizabeth T Golub; D Heather Watts; Galit Alter; Mary A Young; Athe M N Tsibris
Journal:  J Infect Dis       Date:  2015-04-20       Impact factor: 5.226

5.  Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.

Authors:  Gretchen S Stuart; Agnes Moses; Amanda Corbett; Grace Phiri; Wiza Kumwenda; Nkhafwire Mkandawire; Joseph Chintedze; Gabriel Malunga; Mina Hosseinipour; Myron S Cohen; Frank Z Stanczyk; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

6.  Effects of tobacco smoking and oral contraceptive use on theophylline disposition.

Authors:  M J Gardner; K M Tornatore; W J Jusko; R Kanarkowski
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

7.  Pharmacokinetics of levonorgestrel in Indian women.

Authors:  K Madhavan Nair; B Sivakumar; K Prema; B S Narasinga Rao
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 9.  Levonorgestrel. Clinical pharmacokinetics.

Authors:  K Fotherby
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

10.  Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.

Authors:  Alison B Edelman; Ganesh Cherala; Myrna Y Munar; Barent Dubois; Martha McInnis; Frank Z Stanczyk; Jeffrey T Jensen
Journal:  Contraception       Date:  2012-11-12       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.